P Ferrante Selected Research

P Ferrante Research Topics

11	Multiple Sclerosis 12/2011 - 05/2000
4	Progressive Multifocal Leukoencephalopathy 12/2011 - 02/2001
3	Breast Neoplasms (Breast Cancer) 12/2003 - 04/2003
3	Neoplasms (Cancer) 09/2003 - 03/2002
2	HIV Infections (HIV Infection) 10/2011 - 09/2000
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2003 - 04/2003
2	Relapsing-Remitting Multiple Sclerosis 12/2001 - 05/2000
2	Acquired Immunodeficiency Syndrome (AIDS) 02/2001 - 01/2000
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2011
1	Rheumatoid Arthritis 12/2011
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2011
1	Atherosclerosis 01/2011
1	Atherosclerotic Plaque (Atheroma) 01/2011
1	Polyneuropathies (Polyneuropathy) 12/2008
1	Lung Neoplasms (Lung Cancer) 07/2008
1	Anterior Uveitis 07/2008
1	Uveitis 07/2008
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 06/2006
1	Ovarian Neoplasms (Ovarian Cancer) 07/2005
1	Demyelinating Diseases (Demyelinating Disease) 04/2005
1	Atrophy 03/2004
1	Cerebellar Ataxia (Dysmetria) 03/2004
1	Hypogonadism (Hypergonadotropic Hypogonadism) 03/2004
1	Pathologic Complete Response 12/2003
1	Leukemia 12/2003
1	Genetic Predisposition to Disease (Genetic Predisposition) 08/2003
1	Glioblastoma (Glioblastoma Multiforme) 03/2002
1	Carcinoma (Carcinomatosis) 05/2001
1	Ovarian Epithelial Carcinoma 05/2001
1	Disease Progression 05/2000
1	Autoimmune Hepatitis 05/2000
1	Infections 05/2000
1	Autoimmune Diseases (Autoimmune Disease) 05/2000
1	Cachexia 01/2000
1	Lipodystrophy 01/2000

4	CytokinesIBA 12/2001 - 01/2000
3	DNA (Deoxyribonucleic Acid)IBA 01/2011 - 02/2001
3	Myelin Basic ProteinIBA 08/2003 - 05/2000
2	Monoclonal AntibodiesIBA 12/2011 - 12/2001
2	Natalizumab (Tysabri)FDA Link 12/2011 - 03/2007
2	Rituximab (Mabthera)FDA Link 12/2011 - 06/2006
2	HLA-DRB1 Chains (HLA DRB1)IBA 12/2008 - 12/2001
2	Proteins (Proteins, Gene)FDA Link 04/2005 - 05/2000
2	Tumor Viral Antigens (Large T Antigen)IBA 03/2002 - 02/2001
2	AntigensIBA 12/2001 - 05/2000
2	AntibodiesIBA 05/2000 - 05/2000
1	efalizumab (Raptiva)FDA Link 12/2011
1	AsbestosIBA 07/2008
1	ProstaglandinsIBA 07/2008
1	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 07/2008
1	Interferon beta-1a FDA Link 03/2007
1	syncytinIBA 04/2005
1	coenzyme Q10 (CoQ10)IBA 03/2004
1	Mitoxantrone (Novantrone)FDA LinkGeneric 12/2003
1	Oncogene Proteins (Oncogene Protein)IBA 03/2002
1	Capsid Proteins (Capsid Protein)IBA 03/2002
1	Viral DNAIBA 03/2002
1	staphylococcal enterotoxin BIBA 12/2001
1	Genetic Markers (Genetic Marker)IBA 04/2001
1	NucleotidesIBA 02/2001
1	Endothelins (Endothelin)IBA 05/2000
1	Interferon-betaIBA 05/2000
1	Glycoproteins (Glycoprotein)IBA 05/2000
1	EpitopesIBA 05/2000
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2000
1	Complement System Proteins (Complement)IBA 05/2000
1	AutoantibodiesIBA 05/2000
1	MitogensIBA 05/2000
1	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 05/2000
1	NF-kappa B (NF-kB)IBA 01/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2000

6	Therapeutics 12/2011 - 12/2001
5	Drug Therapy (Chemotherapy) 07/2005 - 05/2001
4	Transplantation 07/2005 - 05/2001
2	Highly Active Antiretroviral Therapy (HAART) 10/2011 - 01/2000
1	Aftercare (After-Treatment) 06/2006
1	Stem Cell Transplantation 12/2003
1	Hematopoietic Stem Cell Transplantation 09/2003